Biodegradable nanoparticles composed of enantiomeric poly(γ-glutamic acid)-graft-poly(lactide) copolymers as vaccine carriers for dominant induction of cellular immunity

被引:15
作者
Akagi, Takami [1 ]
Zhu, Ye [1 ]
Shima, Fumiaki [1 ]
Akashi, Mitsuru [1 ]
机构
[1] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan
基金
日本学术振兴会;
关键词
HUMAN DENDRITIC CELLS; STEREOCOMPLEX FORMATION; DEGRADATION; POLY(L-LACTIDE); HYDROLYSIS; DELIVERY; ANTIGEN; SIZE; PH; MORPHOLOGY;
D O I
10.1039/c3bm60279f
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
The design of particulate materials with controlled degradation at desired sites is important in applications for drug/vaccine/gene delivery systems. Amphiphilic biodegradable polymeric nanoparticles are promising vaccine delivery carriers due to their ability to stably maintain antigens, provide tailored release kinetics, effectively target, and function as adjuvants. In this study, we report that stereocomplex nanoparticles (SC NPs) composed of enantiomeric poly(gamma-glutamic acid)-graft-poly(lactide) (gamma-PGA-PLA) copolymers are excellent protein delivery carriers for vaccines that can deliver antigenic proteins to dendritic cells (DCs) and elicit potent immune responses. We prepared ovalbumin (OVA)-encapsulated gamma-PGA-PLA SC NPs (OVA-SC NPs) and isomer NPs. These NPs were efficiently taken up by DCs and also affected the intracellular degradation of the encapsulated OVA. The degradation of OVA encapsulated into the SC NPs was attenuated as compared to free OVA and the corresponding isomer NPs. Interestingly, immunization with OVA-SC NPs predominantly induced antigen-specific cellular immunity. The crystalline structure of inner NPs consisting of PLA had a significant impact on the degradation profiles of NPs and the release/degradation behavior of encapsulated antigens and thus the efficiency of immune induction. Our findings suggest that the.-PGA-PLA SC NPs are suitable for protein-based vaccines that are used to induce cellular immunity, such as for infectious diseases, cancer, allergies and autoimmune diseases.
引用
收藏
页码:530 / 537
页数:8
相关论文
共 40 条
[1]   Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives [J].
Akagi, Takami ;
Wang, Xin ;
Uto, Tomofumi ;
Baba, Masanori ;
Akashi, Mitsuru .
BIOMATERIALS, 2007, 28 (23) :3427-3436
[2]   Intracellular degradation and distribution of protein-encapsulated amphiphilic poly(amino acid) nanoparticles [J].
Akagi, Takami ;
Shima, Fumiaki ;
Akashi, Mitsuru .
BIOMATERIALS, 2011, 32 (21) :4959-4967
[3]   pH-Dependent Disruption of Erythrocyte Membrane by Amphiphilic Poly(amino acid) Nanoparticles [J].
Akagi, Takami ;
Kim, Hyungjin ;
Akashi, Mitsuru .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2010, 21 (03) :315-328
[4]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[5]   Mechanism of the stereocomplex formation between enantiomeric poly(lactide)s [J].
Brizzolara, D ;
Cantow, HJ ;
Diederichs, K ;
Keller, E ;
Domb, AJ .
MACROMOLECULES, 1996, 29 (01) :191-197
[6]   DEGRADATION OF HIGH-MOLECULAR-WEIGHT POLY(L-LACTIDE) IN ALKALINE-MEDIUM [J].
CAM, D ;
HYON, SH ;
IKADA, Y .
BIOMATERIALS, 1995, 16 (11) :833-843
[7]   Self-Assembly Strategy for the Preparation of Polymer-Based Nanoparticles for Drug and Gene Delivery [J].
Chen, Si ;
Cheng, Si-Xue ;
Zhuo, Ren-Xi .
MACROMOLECULAR BIOSCIENCE, 2011, 11 (05) :576-589
[8]   Regulated portals of entry into the cell [J].
Conner, SD ;
Schmid, SL .
NATURE, 2003, 422 (6927) :37-44
[9]   Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro [J].
Cruz, Luis J. ;
Tacken, Paul J. ;
Fokkink, Remco ;
Joosten, Ben ;
Stuart, Martien Cohen ;
Albericio, Fernando ;
Torensma, Ruurd ;
Figdor, Carl G. .
JOURNAL OF CONTROLLED RELEASE, 2010, 144 (02) :118-126
[10]   Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model [J].
Foged, C ;
Brodin, B ;
Frokjaer, S ;
Sundblad, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 298 (02) :315-322